The ASEAN Neurovascular Catheters Market is projected to grow from US$ 63.3 million in 2024 to US$ 162.8 million by 2033, registering a CAGR of 11.1% between 2025 and 2033.
The ASEAN region—including Indonesia, Malaysia, Thailand, Singapore, Vietnam, and the Philippines—is experiencing strong market expansion driven by rising stroke prevalence, aging populations, and increasing adoption of minimally invasive neurovascular procedures. Rapid improvements in healthcare infrastructure, particularly in countries such as Singapore, Malaysia, Thailand, Indonesia, and Vietnam, have supported the development of comprehensive stroke centers, advanced endovascular suites, and specialized neurointerventional services.
Growing awareness of ischemic stroke and cerebral aneurysms, along with government-led initiatives focused on early diagnosis and timely intervention, is fueling demand for advanced neurovascular catheter systems, including thrombectomy catheters, embolization catheters, and microcatheters. Coated catheters are increasingly preferred due to infection-control priorities, particularly in tertiary and private hospitals, while multi-lumen catheters are gaining traction in intensive care units for simultaneous delivery of fluids and medications. Hospitals and clinics remain the dominant end users, supported by high procedural volumes and expanding neurointerventional departments.
Market dynamics vary significantly across the region. Singapore and Malaysia are characterized by early adoption of advanced catheter technologies, while Indonesia and Vietnam emphasize affordability and broader distribution access. Competitive participation includes global players such as Terumo Neuro, Penumbra Inc., Stryker, and Boston Scientific, alongside regional distributors that improve market penetration in fragmented healthcare systems. The combination of rising procedural volumes, infrastructure investment, and technological advancement positions ASEAN as a high-growth region for neurovascular catheter manufacturers.
Market Segmentation Overview
The ASEAN Neurovascular Catheters Market is segmented by product type, coating type, lumen configuration, and end user.
By Product
The market includes thrombectomy catheters, embolization catheters, microcatheters, IVUS catheters, balloon catheters, and others. The thrombectomy catheter segment dominated the market in 2024, driven by its widespread use in acute ischemic stroke treatment.
By Coating Type
The market is categorized into coated and uncoated catheters. Coated catheters led the market in 2024 due to increasing focus on infection prevention and improved biocompatibility.
By Lumen
The segmentation includes single-lumen and multi-lumen catheters. Multi-lumen catheters held the largest share in 2024, owing to their ability to support simultaneous therapeutic delivery in critical care settings.
By End User
Hospitals and clinics, diagnostic imaging centers, and others form the key segments. Hospitals and clinics dominated the market in 2024 due to expanding neurointerventional capabilities and rising stroke treatment volumes.
Key Market Driver: Rising Stroke and Aneurysm Burden
Stroke and cerebral aneurysms represent a significant and growing health challenge across ASEAN countries, driven by aging populations and increasing prevalence of risk factors such as hypertension, diabetes, obesity, and atrial fibrillation.
Ischemic stroke accounts for the majority of cases and remains one of the leading causes of death and long-term disability in Southeast Asia. Mechanical thrombectomy has become the standard of care for large vessel occlusions, requiring neurovascular catheters for rapid clot retrieval, vessel recanalization, and neurological damage reduction.
In parallel, cerebral aneurysms are increasingly detected due to improved diagnostic imaging capabilities in urban hospitals. These conditions are often treated using minimally invasive procedures such as coil embolization and flow diversion, which depend on highly specialized microcatheters for precise device delivery. Expanding awareness programs and government-led stroke initiatives are further increasing procedural volumes across the region.
Key Market Opportunity: MedTech–Hospital Collaboration
Strategic partnerships between hospitals and medical technology companies are accelerating innovation and adoption in the ASEAN neurovascular catheters market. These collaborations include co-development programs, clinical trials, and physician training initiatives that support improved procedural outcomes and faster technology adoption.
For manufacturers, these partnerships provide direct insights into clinical workflows, enabling the development of catheters with enhanced flexibility, navigability, and precision. Hospitals benefit from early access to advanced technologies, customized device solutions, and structured training programs for neurointerventional specialists.
Clinical research collaborations also generate real-world evidence that supports regulatory approvals, reimbursement decisions, and clinical guideline adoption. In addition, simulation-based training programs enhance physician competency and increase procedural efficiency.
Given ASEAN’s mixed healthcare landscape—ranging from advanced systems in Singapore and Malaysia to emerging markets in Indonesia, Vietnam, and the Philippines—such collaborations are critical for ensuring market penetration, regulatory alignment, and long-term adoption of neurovascular technologies.
Country-Level Analysis
The ASEAN market includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, and Vietnam, with Indonesia holding the largest share in 2024.
Indonesia leads the region due to its large population, increasing stroke incidence, and expanding hospital infrastructure with neurointerventional capabilities in major cities such as Jakarta, Surabaya, and Bandung. Singapore and Malaysia represent mature markets with advanced stroke systems, high imaging adoption, and early uptake of coated and multi-lumen catheters.
Thailand and the Philippines are witnessing steady growth driven by healthcare reforms and improved access to endovascular procedures. Vietnam is emerging as a high-potential market supported by investments in healthcare infrastructure and specialist training programs. Across ASEAN, hospitals and clinics remain the primary end users, while diagnostic and specialty centers are increasingly adopting advanced catheter technologies.
Recent Industry Developments
In October 2025, Penumbra Inc. introduced the SwiftSET neuro embolization coil to enhance precision and efficiency in intracranial aneurysm treatment, strengthening its presence in ASEAN markets.
In June 2025, Stryker launched the AXS Lift intracranial base catheter, designed to improve support and navigation in complex neurovascular procedures, including thrombectomy and embolization across Southeast Asia.